HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

canakinumab

a human anti-interleukin-1beta monoclonal antibody for treatment of cryopyrin-associated periodic syndrome
Also Known As:
ACZ-885; ACZ885; Ilaris; immunoglobulin G1, anti-(human interleukin 1beta) (human clone ACZ885 heavy chain V region)
Networked: 552 relevant articles (100 outcomes, 208 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Ridker, Paul M: 25 articles (12/2021 - 10/2011)
2. Libby, Peter: 19 articles (10/2022 - 10/2011)
3. Thuren, Tom: 17 articles (10/2020 - 10/2011)
4. Everett, Brendan M: 13 articles (12/2021 - 01/2017)
5. Glynn, Robert J: 13 articles (12/2021 - 01/2017)
6. Kuemmerle-Deschner, Jasmin B: 13 articles (02/2021 - 06/2009)
7. Cantarini, Luca: 13 articles (01/2020 - 06/2012)
8. MacFadyen, Jean G: 11 articles (12/2021 - 01/2017)
9. Martini, Alberto: 10 articles (01/2022 - 02/2012)
10. Quartier, Pierre: 10 articles (01/2021 - 06/2009)

Related Diseases

1. Inflammation (Inflammations)
2. Cryopyrin-Associated Periodic Syndromes
3. Familial Mediterranean Fever (Periodic Disease)
4. Thrombosis (Thrombus)
5. Juvenile Arthritis (Juvenile Idiopathic Arthritis)

Related Drugs and Biologics

1. Interleukin 1 Receptor Antagonist Protein (Anakinra)
2. Colchicine
3. Monoclonal Antibodies
4. Interleukin-1 (Interleukin 1)
5. rilonacept
6. tocilizumab (atlizumab)
7. Interleukin-1 Receptors (Interleukin 1 Receptor)
8. C-Reactive Protein
9. Triamcinolone Acetonide (Azmacort)
10. gevokizumab

Related Therapies and Procedures

1. Therapeutics
2. Secondary Prevention
3. Contraindications
4. Off-Label Use
5. Biological Therapy